The Morning Brief

India's largest drugmaker, Sun Pharma, has announced the acquisition of US-based Organon in a landmark $11.75 billion all-cash deal, the biggest overseas purchase by an Indian company since Tata-Corus in 2007. The move effectively doubles Sun Pharma's size, vaulting it into the top 25 global pharmaceutical companies with combined revenues of $12.4 billion. Host Anirban Chowdhury talks to ET's pharma expert Vikas Dandekar and associate editor Arijit Barman about why this deal gives Sun Pharma an instant foothold in biosimilars, a dominant position in global women's health, and a portfolio of established brands across 150 countries. With $2.5 billion in combined pre-financing free cash flows, the company looks well-positioned to tackle Organon's inherited debt burden.See omnystudio.com/listener for privacy information.

West Bengal's 2026 elections should be a contest of ideas but on the ground, something far darker is unfolding. What emerges from ground reporting is not voters debating whom to choose, but fearing whether they'll be allowed to vote at all. Booth capturing, voter list manipulation, and intimidation have replaced genuine democratic exercise. While TMC faces anti-incumbency after 15 years and BJP pushes hard, is the real casualty democracy itself? Host Nidhi Sharma talks to ET’s Jayatri Nag, Kumar Anshuman and a prominent senior journalist and columnist, Shikha Mukerjee why Bengal isn't just testing political loyalty, it's testing whether free and fair elections still exist in India.You can follow our host Nidhi Sharma on her social media: Twitter & LinkedinCheck out other interesting episodes like: India's Medical Tourism Slips Off the Table, ET Deep Dive:The Van That Ate the SUV, Quantum Leap: India’s Amaravati Bet, Can India Truly End Naxalism?, Semaglutide Goes Generic: Big Pharma’s Moat Breaks  and much more. Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn,  Amazon Music and Google Podcasts.Credits:  Dev Official SingerSee omnystudio.com/listener for privacy information.

Online dating has always been a grueling hustle, but a new, invisible third wheel has entered the chat: Artificial Intelligence. In this episode of ET Deep Dive, we explore how AI has quietly wedged itself into modern romance. From perfectly crafted opening lines to entirely automated textationships, lonely daters are now outsourcing their emotional labor and linguistic charm to chatbots. But what happens when witty banter online translates to an underwhelming stranger offline? We unpack the fatigue, the growing mistrust, and the psychological rupture of discovering your perfect match is merely an algorithm. Are we losing our basic human connection?Nupur amarnath reports, And Dia Rekhi narrates. See omnystudio.com/listener for privacy information.

Tamil Nadu heads to the polls with its familiar two-party battle DMK vs AIADMK facing an unprecedented challenge. Actor-turned-politician Vijay and his party TVK are injecting fresh uncertainty into a state that has ritually voted out incumbents since 1967. With law and order, corruption, and drugs dominating voter anxieties, MK Stalin's "Dravidian model" faces a tough stress test. Vijay's caste-neutral identity and populist promises are drawing the youth away from established loyalties. In 120 seats won by razor-thin margins, even a vote-splitter can rewrite history. Host Nidhi Sharma talks to ET’s Dia Rekhi and Krishna Kumar how April 23 could be one Tamil Nadu's most consequential elections.You can follow our host Nidhi Sharma on her social media: Twitter & LinkedinCheck out other interesting episodes like: How Will a Volatile ₹ Impact You in 2026?, How Quick Commerce is Triggering a Health Crisis for Gen Z, Two Women Fought to Change India's Maternity Laws...and Succeeded, Can India Truly End Naxalism?, Semaglutide Goes Generic: Big Pharma’s Moat Breaks  and much more. Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn,  Amazon Music and Google Podcasts.Credits: KCH MovementSee omnystudio.com/listener for privacy information.

India's medical tourism industry is in a quiet downturn. Foreign patient arrivals have fallen roughly a third since 2019 from nearly 700,000 visitors to around 500,000 dragged down by strained ties with Bangladesh, visa processing times stretching up to 60 days, and aggressive competition from Thailand, Malaysia, and Singapore. A tax incidence on medical referrals threatens to push costs higher just as global insurers remain largely unempanelled with Indian hospitals. The silver lining: average revenue per patient is rising, as high-value procedures like oncology and cardiac surgery now dominate. Host Anirban Chowdhury talks to ET’s Forum Gandhi and  pharma editor Vikas Dandekar about the problem, its reasons and fixes. Listen in:You can follow Anirban Chowdhury on his social media: X and LinkedinCheck out other interesting episodes like: How Will a Volatile ₹ Impact You in 2026?, How Quick Commerce is Triggering a Health Crisis for Gen Z, Two Women Fought to Change India's Maternity Laws...and Succeeded, Can India Truly End Naxalism?, Semaglutide Goes Generic: Big Pharma’s Moat Breaks  and much more. Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.